Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

265

HTML

2238

Figures (1-3)

301

Tables (1-4)

270

Sum=3074

Dec 21, 2008 (publication date) through Mar 7, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 21, 2008; 14(47): 7225-7230
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7225

Table 3 Multivariate analysis of association between sustained virological response and influential factors

Factor	Coefficient	χ²	Odds ratio (95% CI)	P
EVR (not achieved)	-2.725	19.325	0.066 (0.019-0.221)	< 0.0001
Cumulative exposure to peg-IFN
Overall (≥ 80%)	2.392	6.600	10.934 (1.763-67.82)	0.0102
Constant	1.294

EVR: Early virological response; Peg-IFN: Pegylated interferon.

Citation: Kogure T, Ueno Y, Fukushima K, Nagasaki F, Kondo Y, Inoue J, Matsuda Y, Kakazu E, Yamamoto T, Onodera H, Miyazaki Y, Okamoto H, Akahane T, Kobayashi T, Mano Y, Iwasaki T, Ishii M, Shimosegawa T. Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan. World J Gastroenterol 2008; 14(47): 7225-7230
URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7225.htm
DOI: https://dx.doi.org/10.3748/wjg.14.7225